Literature DB >> 22633190

Quantification of contralateral breast dose and risk estimate of radiation-induced contralateral breast cancer among young women using tangential fields and different modes of breathing.

Brigitte Zurl1, Heidi Stranzl, Peter Winkler, Karin Sigrid Kapp.   

Abstract

PURPOSE: Whole breast irradiation with deep-inspiration breath-hold (DIBH) technique among left-sided breast cancer patients significantly reduces cardiac irradiation; however, a potential disadvantage is increased incidental irradiation of the contralateral breast. METHODS AND MATERIALS: Contralateral breast dose (CBD) was calculated by comparing 400 treatment plans of 200 left-sided breast cancer patients whose tangential fields had been planned on gated and nongated CT data sets. Various anatomic and field parameters were analyzed for their impact on CBD. For a subgroup of patients (aged ≤45 years) second cancer risk in the contralateral breast (CB) was modeled by applying the linear quadratic model, compound models, and compound models considering dose-volume information (DVH).
RESULTS: The mean CBD was significantly higher in DIBH with 0.69 Gy compared with 0.65 Gy in normal breathing (P=.01). The greatest impact on CBD was due to a shift of the inner field margin toward the CB in DIBH (mean 0.4 cm; range, 0-2), followed by field size in magnitude. Calculation with different risk models for CBC revealed values of excess relative risk/Gy ranging from 0.48-0.65 vs 0.46-0.61 for DIBH vs normal breathing, respectively.
CONCLUSION: Contralateral breast dose, although within a low dose range, was mildly but significantly increased in 200 treatment plans generated under gated conditions, predominately due to a shift in the medial field margin. Risk modeling for CBC among women aged ≤45 years also pointed to a higher risk when comparing DIBH with normal breathing. This risk, however, was substantially lower in the model considering DVH information. We think that clinical decisions should not be affected by this small increase in CBD with DIBH because DIBH is effective in reducing the dose to the heart in all patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633190     DOI: 10.1016/j.ijrobp.2012.04.016

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Authors:  Carolyn Taylor; Candace Correa; Frances K Duane; Marianne C Aznar; Stewart J Anderson; Jonas Bergh; David Dodwell; Marianne Ewertz; Richard Gray; Reshma Jagsi; Lori Pierce; Kathleen I Pritchard; Sandra Swain; Zhe Wang; Yaochen Wang; Tim Whelan; Richard Peto; Paul McGale
Journal:  J Clin Oncol       Date:  2017-03-20       Impact factor: 44.544

2.  Cardiac dose-sparing effects of deep-inspiration breath-hold in left breast irradiation : Is IMRT more beneficial than VMAT?

Authors:  Mazen Sakka; Leonie Kunzelmann; Martin Metzger; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2017-06-23       Impact factor: 3.621

3.  Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?

Authors:  Vanessa Figlia; Cristoforo Simonetto; Markus Eidemüller; Stefania Naccarato; Gianluisa Sicignano; Antonio De Simone; Ruggero Ruggieri; Rosario Mazzola; Christiane Matuschek; Edwin Bölke; Montserrat Pazos; Maximilian Niyazi; Claus Belka; Filippo Alongi; Stefanie Corradini
Journal:  Breast Care (Basel)       Date:  2020-10-19       Impact factor: 2.268

4.  Contralateral breast dose from partial breast brachytherapy.

Authors:  R Cole Robinson; Christopher L Nelson; Elizabeth S Bloom; Kelly D Kisling; Bryan E Mason; Gary D Fisher; Steven M Kirsner
Journal:  J Appl Clin Med Phys       Date:  2015-11-08       Impact factor: 2.102

5.  Comparison of Breast Cancer Radiotherapy Techniques Regarding Secondary Cancer Risk and Normal Tissue Complication Probability - Modelling and Measurements Using a 3D-Printed Phantom.

Authors:  Marc Vogel; Jonas Gade; Bernd Timm; Michaela Schürmann; Hendrik Auerbach; Frank Nüsken; Christian Rübe; Patrick Melchior; Yvonne Dzierma
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.